Compare ALRM & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALRM | HCM |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2015 | 2015 |
| Metric | ALRM | HCM |
|---|---|---|
| Price | $53.88 | $13.75 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $56.67 | $13.75 |
| AVG Volume (30 Days) | ★ 332.7K | 77.2K |
| Earning Date | 05-07-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $1,011,187,000.00 | N/A |
| Revenue This Year | $7.00 | $20.60 |
| Revenue Next Year | $4.53 | $15.62 |
| P/E Ratio | $57.11 | ★ $5.49 |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $41.49 | $9.77 |
| 52 Week High | $58.15 | $16.99 |
| Indicator | ALRM | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.21 | 59.84 |
| Support Level | $50.39 | $12.94 |
| Resistance Level | $54.85 | $15.43 |
| Average True Range (ATR) | 1.36 | 0.32 |
| MACD | -0.38 | 0.03 |
| Stochastic Oscillator | 12.75 | 75.76 |
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected device.
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.